Abstract
Adenosine is used as pharmacological treatment of the first choice for the termination of regular small complex tachycardia. Although it is considered safe in this context, several reports of short lasting proarrythmic effects have been described. We present a case of a sustained monomorphic ventricular tachycardia following adenosine infusion.
MeSH terms
-
Adenosine / administration & dosage
-
Adenosine / adverse effects*
-
Adenosine / therapeutic use
-
Adult
-
Anti-Arrhythmia Agents / administration & dosage
-
Anti-Arrhythmia Agents / adverse effects*
-
Anti-Arrhythmia Agents / therapeutic use
-
Electrocardiography
-
Female
-
Heart Rate
-
Humans
-
Injections, Intravenous
-
Tachycardia / diagnosis
-
Tachycardia / drug therapy*
-
Tachycardia, Ventricular / chemically induced*
-
Tachycardia, Ventricular / physiopathology*
-
Ventricular Premature Complexes / chemically induced
-
Ventricular Premature Complexes / diagnosis
Substances
-
Anti-Arrhythmia Agents
-
Adenosine